The United States Food and Drug Administration has approved a new drug produced by the Israeli company Teva Pharmaceuticals, the world’s largest producer of generic drugs. The new drug, Gemcitabine, is used to treat cancer. It is based on the drug Gemzar, produced by Eli Lilly.
Eli Lilly has filed a complaint against Teva, accusing the company of violating two patents in its development of Gemcitabine. Teva will be allowed to sell Gemcitabine on the American market when the case is resolved.
Sales of Gemzar are currently approximately $660 million a year in the United States.